Evogene Ltd (EVGN) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access EVGN Annual Balance Sheets →
Looking at balance sheet data from Evogene Ltd through Dec 31 2024 provides insight into Dec 31 2025's solvency and capital structure over time.
Quarterly Report, GAAP in USD millions
ITEM
(Dec 31 2025)
0 0 0 (Dec 31 2024)
Assets
Cash And Cash Equivalents12.96
Cash & Short-term Investments12.00
Accounts receivable0.32
Inventories0.21
Other Current Assets2.15
Total Current Assets15.63
Equipment/Property/Plant Net0.81
Intangible Assets0.00
Other Assets, Noncurrent3.60
Total Assets20.05
Liabilities
Accounts Payable0.64
Other Liabilities, Current3.44
Total Current Liabilities3.44
Total Long-term Debt0.00
Other liabilities, Noncurrent3.99
Total Liabilities8.07
Stockholders' Equity
Other Equity11.32
Common Stockholder's Equity11.32
Total Stockholder's Equity11.98
Liabilities & Stockholder's Equity20.05
4 historic quarters locked

Sign in to unlock the full Evogene Ltd balance sheet history.

About Evogene Ltd Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 20-F filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

  • Form: 20-F (Period: 20251231)
  • Filed with the SEC: March 26, 2026
  • Source: zk2634882.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001178913-26-001767

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.